Approval · Notice of Compliance 10716 · 2009
ACTOS: Notice of Compliance 10716
Issued October 26, 2009
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 10716
- Date
- October 26, 2009
- Company
- Takeda Canada IncorporatedToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Anti-diabetic agent / Insulin resistance reducing agent
Products in this notice
Medicinal ingredients
- PIOGLITAZONE HYDROCHLORIDE 15 MG per TAB
- PIOGLITAZONE HYDROCHLORIDE 30 MG per TAB
- PIOGLITAZONE HYDROCHLORIDE 45 MG per TAB